Buscar
Mostrando ítems 111-120 de 226
Phenotypic variability in a family with haemophilia B and prothrombin G20210A
(2012)
[No abstract available]
Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: A comprehensive Argentine study of inhibitor risks
(Wiley Blackwell Publishing, Inc, 2013-07)
Inhibitor development against exogenous factor VIII is a severe impairment of replacement therapy affecting 18% of Argentine patients with severe haemophilia A (HA). To study the molecular predisposition for inhibitor ...
F8 intron 22 inversions and SNP rs73563631 in unrelated families with severe haemophilia A: clinical features and gene testing implications
(Schattauer Gmbh-Verlag Medizin Naturwissenschaften, 2015-10)
F8 intron 22 inversions (INV22), the commonest cause of severe haemophilia A (HA), are mostly represented by type I (INV22-1) and type II (INV22-2) patterns (4:1) using BclI-fragments´ based techniques such as inverse ...
Avaliação da adesão ao tratamento profilático na hemofilia: estudo transversal no interior do Estado de São Paulo (Brasil)
(Universidade Estadual Paulista (UNESP), 2016)
Zika Virus And Inherited Bleeding Disorders
(Wiley-BlackwellHoboken, 2017)
Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors
(2014)
In Mexico, 15% of haemophilia A (HA) patients develop inhibitory alloantibodies in response to replacement therapy with factor VIII (FVIII), requiring bypass therapy such as activated prothrombin complex concentrate (APCC). ...